OL
DGX icon

Optas LLC’s Quest Diagnostics DGX Stock Holding History

Optas LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Sell
1,482
-222
-13% -$43.6K 0.04% 301
2026
Q1 		$334K Sell
1,704
-143
-8% -$27.8K 0.05% 275
2025
Q4 		$321K Buy
+1,847
New +$336K 0.05% 278

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Optas LLC's DGX Position: Q2 2026 in Review

Optas LLC reduced its Quest Diagnostics (DGX) stake by 13% in Q2 2026, selling an estimated $43.6K and leaving 1,482 shares worth $314K. The position accounts for 0.04% of the portfolio, ranked #301.

Optas LLC first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. The position peaked at $334K in Q1 2026. 268 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Optas LLC held 1,482 shares of Quest Diagnostics worth $314K as of Q2 2026.
  • Optas LLC sold 222 Quest Diagnostics shares in Q2 2026, an estimated $43.6K.
  • Quest Diagnostics made up 0.04% of Optas LLC's portfolio in Q2 2026, its #301 holding.
  • Optas LLC first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • Optas LLC's Quest Diagnostics position peaked at $334K in Q1 2026.
  • 268 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.